Ontario issues two suspensions for DPO

As a result of an investigation by the industry-funded Equine Medication Control and Drug Task Force, and after tests confirmed the presence of darbepoetin-alfa (DPO) in horses, the director of the Ontario Racing Commission has ordered the immediate suspension of the licenses of two people, Daniel McFadden of Windsor, Ont., and Scott McFadden of Cottam, Ont.

Investigators had received information that a number of prescriptions were being written for the drug Aranesp, and were being filled at a Windsor area pharmacy. Aranesp is a brand name form of darbepoetin-alfa.

As a result of the information, out-of-competition testing was conducted on horses trained by Daniel McFadden. The tests confirmed the presence of erythropeietin/darbepoetin-alfa in blood samples taken from two horses at the relevant time. Scott McFadden is the owner of the horses.

Also, as a result of these positive tests, the horses Reasontocelebrate and Dr Sharkey have been declared ineligible to race in Ontario for a period of 90 days from Dec. 8, 2008. This suspension is made under the terms of the new Horse Positive (Owner Responsibility) rule (SB11.10.01) which came into effect Jan. 31, 2008.

A further investigation of these and other individuals is underway and the director may take additional action in this matter.

Erythropeietin is commonly known as EPO. DPO is classed as a potent long-lasting form of EPO. Evidence presented at ORC hearings over the past year has confirmed that EPO/DPO has no legitimate use for a horse that is racing. It not only places the horse at risk, it imperils the future of the horse racing industry.

It is disturbing that a handful of individuals continue to use such illegal medications with a complete disregard for the health of the horse and the welfare of the thousands of people who work in the racing community. By far the majority of those licensed in that community conduct their business with professionalism, abide by the rules and care passionately about the horse.

Through its continued support of the Equine Medication Control and Drug Task Force, the industry will reinforce the message that the acquisition, possession and administration of illegal and non-therapeutic drugs will not be tolerated. (ORC)

« Back